BSE Live
Apr 10, 16:01Prev. Close
82.35
Open Price
83.49
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Denis Chem Lab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | |
| Total Share Capital | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | |
| Reserves and Surplus | 71.23 | 66.49 | 58.39 | 52.57 | 47.63 | |
| Total Reserves and Surplus | 71.23 | 66.49 | 58.39 | 52.57 | 47.63 | |
| Total Shareholders Funds | 85.10 | 80.37 | 72.26 | 66.45 | 61.50 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.45 | 0.45 | 0.92 | 2.18 | 4.46 | |
| Deferred Tax Liabilities [Net] | 0.11 | 0.96 | 1.94 | 1.86 | 0.83 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.43 | 0.37 | 0.24 | 0.60 | 1.33 | |
| Total Non-Current Liabilities | 1.00 | 1.79 | 3.11 | 4.63 | 6.62 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.37 | 0.59 | 1.01 | 1.04 | 4.69 | |
| Trade Payables | 21.24 | 21.41 | 18.28 | 19.70 | 15.67 | |
| Other Current Liabilities | 4.51 | 4.69 | 4.75 | 4.12 | 3.28 | |
| Short Term Provisions | 0.06 | 0.51 | 0.03 | 0.45 | 0.50 | |
| Total Current Liabilities | 26.17 | 27.20 | 24.08 | 25.31 | 24.14 | |
| Total Capital And Liabilities | 112.27 | 109.35 | 99.45 | 96.39 | 92.26 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 38.72 | 37.44 | 35.20 | 41.33 | 41.25 | |
| Intangible Assets | 0.11 | 0.18 | 0.22 | 0.00 | 0.14 | |
| Capital Work-In-Progress | 0.07 | 0.22 | 2.13 | 0.33 | 0.08 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 38.90 | 37.84 | 37.54 | 41.66 | 41.47 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 2.73 | 2.13 | 2.66 | 1.27 | 2.24 | |
| Total Non-Current Assets | 41.63 | 39.98 | 40.21 | 42.93 | 43.71 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 9.81 | 10.19 | 9.12 | 9.89 | 9.11 | |
| Trade Receivables | 30.61 | 31.66 | 31.24 | 31.84 | 32.88 | |
| Cash And Cash Equivalents | 26.23 | 24.67 | 16.93 | 9.22 | 4.54 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 3.99 | 2.85 | 1.95 | 2.52 | 2.03 | |
| Total Current Assets | 70.64 | 69.37 | 59.24 | 53.46 | 48.55 | |
| Total Assets | 112.27 | 109.35 | 99.45 | 96.39 | 92.26 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 18.68 | 3.61 | 5.29 | 2.89 | 10.42 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | 3.60 | 3.17 | 3.15 | 4.98 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
27.11.2025
Denis Chem Lab Standalone September 2025 Net Sales at Rs 46.17 crore, down 3.44% Y-o-Y
12.06.2025
Denis Chem Lab Standalone March 2025 Net Sales at Rs 41.38 crore, up 3.84% Y-o-Y
26.11.2024
Denis Chem Lab Standalone September 2024 Net Sales at Rs 47.82 crore, up 5.26% Y-o-Y
17.08.2024
Denis Chem Lab Standalone June 2024 Net Sales at Rs 41.26 crore, down 2.88% Y-o-Y
27.11.2025
Denis Chem Lab Standalone September 2025 Net Sales at Rs 46.17 crore, down 3.44% Y-o-Y
12.06.2025
Denis Chem Lab Standalone March 2025 Net Sales at Rs 41.38 crore, up 3.84% Y-o-Y
26.11.2024
Denis Chem Lab Standalone September 2024 Net Sales at Rs 47.82 crore, up 5.26% Y-o-Y
17.08.2024
Denis Chem Lab Standalone June 2024 Net Sales at Rs 41.26 crore, down 2.88% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth